Funding agency: 
Damon Runyon Cancer Research Foundation

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.

The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.

Eligible applicants: Tenure Track Assistant Professors within the first five years of obtaining their initial AS position, Clinical Instructors and Senior Clinical Fellows, and Distinguished Fellows. Basic and translational/clinical projects will be considered. Applications accepted from all scientific disciplines.

July 1, 2019
Funding type: